Nautilus Biotechnology, (id:8130 NAUT)
2.40 USD
Opening hours: 09:30 - 16:00 (Eastern Standard Time: 11/24/2024 3:04:46 PM)
Exchange closed, opens in 18 hours 25 minutes
About Nautilus Biotechnology,
Market Capitalization 301.35M
Nautilus Biotechnology, Inc., a development stage life sciences company, engages in creating a platform technology for quantifying and unlocking the complexity of the proteome. The company develops Nautilus Platform, a proteomics platform that includes end-to-end solution comprised of instruments, consumables, and software analysis. It also offers proteome analysis system, a high-resolution optical imaging system for integrated fluidics and liquid handling sub-system. In addition, the company provides sample preparation, flow cells, multi-affinity probe reagents, and instrument buffers system to perform multi-cycle analysis runs. Nautilus Biotechnology, Inc. was incorporated in 2016 and is headquartered in Seattle, Washington.
| Headquarters (address) |
2701 Eastlake Avenue East Seattle 98102 WA United States |
| Phone | 206 333 2001 |
| Website | https://www.nautilus.bio |
| Employees | 161 |
| Sector | Healthcare |
| Industry | Biotechnology |
| Ticker | NAUT |
| Exchange | NASDAQ Stock Exchange |
| Currency | USD |
| 52 week range | 2.19 - 3.46 |
| Market Capitalization | 301.35M |
| P/E trailing | -4.71 |
| P/E forward | -3.24 |
| Price/Book | 1.35 |
| Beta | 1.04 |
| EPS | -0.560 |
| EPS United States (ID:6, base:3402) | 24.22 |